Cidara Thera names biotech vet as new CBO

US biotech Cidara Therapeutics (Nasdaq: CDTX) has appointed sector veteran Jim Beite as its chief business officer (CBO).

Mr Beitel has over 20 years of experience in life science corporate development including strategy, business development, commercialization, finance, and other roles for a variety of companies including biotech, commercial-stage specialty pharma, early-stage venture-backed companies, and multi-national pharmaceutical companies.

Most recently, Mr Beitel was senior vice president of corporate development at Fate Therapeutics, where his record includes strategic partnering in oncology and autoimmune diseases. During Mr Beitel’s career in business development, he has successfully sourced and executed partnering activities which significantly expanded company pipelines, generated over $4 billion in upfront payments and collaboration revenues, and contributed to the ability to raise over $1 billion in equity financings.